Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001014100-12-000047
Filing Date
2012-06-07
Accepted
2012-06-07 15:47:02
Documents
1
Period of Report
2012-01-01

Document Format Files

Seq Description Document Type Size
1 pol1.html 4  
1 pol1.xml 4 10857
  Complete submission text file 0001014100-12-000047.txt   12503
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Issuer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 233 EAST REDWOOD ST BALTIMORE MD 21202
Business Address
Poliakoff Abba David (Reporting) CIK: 0001423066 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17263 | Film No.: 12894856